UBS Group
DRTS icon

UBS Group’s Alpha Tau Medical DRTS Stock Holding History

UBS Group’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.08M Buy
642,263
+355,575
+124% +$3.23M ﹤0.01% 3686
2026
Q1 		$2.03M Buy
286,688
+265,988
+1,285% +$1.88M ﹤0.01% 4969
2025
Q4 		$102K Sell
20,700
-9,919
-32% -$41.8K ﹤0.01% 6900
2025
Q3 		$138K Sell
30,619
-2,700
-8% -$9.19K ﹤0.01% 6900
2025
Q2 		$104K Buy
33,319
+300
+0.9% +$845 ﹤0.01% 7209
2025
Q1 		$82.9K Buy
33,019
+32,949
+47,070% +$103K ﹤0.01% 7191
2024
Q4 		$217 Sell
70
-1,109
-94% -$2.84K ﹤0.01% 9561
2024
Q3 		$2.81K Buy
+1,179
New +$2.61K ﹤0.01% 8363
2024
Q2 		– Sell
-37
Closed -$109 – 9635
2024
Q1 		$109 Buy
+37
New +$114 ﹤0.01% 8830
2023
Q2 		– Sell
-1,292
Closed -$3.71K – 9056
2023
Q1 		$3.71K Sell
1,292
-254
-16% -$886 ﹤0.01% 8287
2022
Q4 		$4.92K Buy
+1,546
New +$6.4K ﹤0.01% 9249
2022
Q3 		– Sell
-1,916
Closed -$17K – 10454
2022
Q2 		$17K Buy
1,916
+1,016
+113% +$9.1K ﹤0.01% 7086
2022
Q1 		$11K Buy
+900
New +$10.6K ﹤0.01% 8291

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

UBS Group's DRTS Position: Q2 2026 in Review

UBS Group increased its Alpha Tau Medical (DRTS) stake by 124% in Q2 2026, buying an estimated $3.23M and bringing the position to 642,263 shares worth $8.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3686.

UBS Group first reported a position in DRTS in Q1 2022 and has held it in 13 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • UBS Group held 642,263 shares of Alpha Tau Medical worth $8.08M as of Q2 2026.
  • UBS Group bought 355,575 Alpha Tau Medical shares in Q2 2026, an estimated $3.23M.
  • Alpha Tau Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3686 holding.
  • UBS Group first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 13 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.